Overview
The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.
Eligibility
Inclusion Criteria:
- Men and women must be at least 18 years of age. Female subjects must meet additional criteria in relation to childbearing potential.
- Subjects must be undergoing a planned first metatarsal bunionectomy with osteotomy and internal fixation (Austin bunionectomy) without collateral procedures.
- Subjects must have the ability to provide written informed consent.
- Subjects must have the ability to understand study procedures and communicate clearly with the Investigator and staff.
Key Exclusion Criteria:
- Subjects undergoing emergency or unplanned surgery.
- Subjects who had any previous bunionectomy procedure on either foot.
- Subjects with pre-existing conditions (other than bunion) causing preoperative pain at the site of surgery.
- Female subjects who are pregnant or breastfeeding.
- Diagnosis of chronic pain and ongoing or frequent use of pain medications.